Longevity research has increasingly moved away from searching for a single mechanism of biological aging and toward a multi-system framework — one in which several parallel processes, each with its own molecular logic, contribute to the progressive decline in cellular function that characterizes aging. Three compounds in the active research literature represent different nodes in this framework: Epitalon, which addresses chromosomal integrity through the telomere/telomerase axis; MOTS-C, which addresses mitochondrial metabolic signaling through AMPK; and NAD+, which addresses cellular energy availability and its downstream effects on sirtuin activity and DNA repair. These are not three versions of the same mechanism — they are three different research areas that converge on the same outcome: understanding how cells age and what signals govern that process.
Published aging research consistently identifies cellular aging as operating through multiple distinct systems rather than a single pathway. The telomere hypothesis, the mitochondrial theory of aging, and the NAD+/sirtuin hypothesis each emerged from independent research programs and each has its own body of published evidence. What researchers have increasingly recognized is that these systems interact: short telomeres affect mitochondrial function, NAD+ availability affects sirtuin-mediated gene regulation of mitochondrial biogenesis, and mitochondrial-derived signals like MOTS-C affect nuclear gene expression. The three compounds discussed in this overview represent research tools for studying each system individually and — where published co-administration models exist — in combination.
—-
Epitalon (also written Epithalon) is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (AEDG). It was derived from Epithalamin, a polypeptide extract from bovine pineal gland tissue, by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology, where it has been studied for over 25 years. The peptide was synthesized to identify the minimal active sequence responsible for the biological properties observed in the larger Epithalamin extract.
Telomeres are repetitive DNA sequences (TTAGGG in humans) that cap the ends of chromosomes and protect them from degradation and inappropriate recombination. With each cell division, telomeres lose a small amount of length — a consequence of the end-replication problem in DNA synthesis. When telomeres reach a critically short length, they trigger replicative senescence or apoptosis, limiting how many times a cell can divide. This telomere shortening is one of the most well-documented molecular mechanisms in aging biology, and telomere length has been proposed as a biomarker of biological age in the published literature.
Telomerase — specifically its catalytic subunit hTERT — is the enzyme capable of extending telomeres by adding telomeric repeats back to chromosome ends. In most adult somatic cells, hTERT expression is suppressed and telomerase activity is minimal. Reactivating telomerase in somatic cells is a major research interest in longevity biology.
The foundational published study on Epitalon and telomere biology is Khavinson et al. 2003, published in the Bulletin of Experimental Biology and Medicine. This study reported that Epitalon treatment of human fetal lung fibroblast cultures reactivated hTERT expression, increased telomerase enzymatic activity (measured via the TRAP assay), and extended the proliferative lifespan of cells beyond the normal Hayflick limit — with treated cultures achieving more than 10 additional population doublings compared to untreated controls, alongside measurable preservation of telomere length.
Khavinson VK, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bull Exp Biol Med. 2003;135(6):590-592.
A 2025 study published in Biogerontology (Springer, doi: 10.1007/s10522-025-10315-x) extended this work by examining Epitalon in multiple human cell line types — including breast cancer cell lines and normal epithelial and fibroblast cells — and quantified effects on telomere length, hTERT mRNA expression, telomerase enzyme activity, and ALT (Alternative Lengthening of Telomeres) activity across different doses. This represents one of the first comprehensive quantitative analyses of the biomolecular pathway through which Epitalon affects telomere length.
Araj et al. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Biogerontology. 2025. doi:10.1007/s10522-025-10315-x
Published animal model research from Khavinson’s group includes longevity studies in Drosophila melanogaster, Sprague-Dawley rat cohorts, and non-human primates, with documented effects on survival rates, tumor incidence, and melatonin rhythm parameters. In a 2003 study published in Mechanisms of Ageing and Development, Epitalon administration to aged female rats was associated with a 13.3% increase in mean lifespan compared to untreated controls, with reduced incidence of spontaneous tumors.
The research community has noted that the majority of published Epitalon studies have originated from Khavinson’s laboratory, and independent replication by external groups has been limited — a caveat that published reviews of this literature consistently acknowledge. The 2025 Springer study represents a more recent independent examination. Human clinical trial data remain limited; a 2023 case report documented changes in telomere length markers and biological age parameters in a single self-administering subject, but this does not constitute controlled clinical evidence. Researchers examining this compound should apply appropriate methodological context when interpreting preclinical and in vitro findings.
—-
MOTS-C (Mitochondrial ORF of the 12S rRNA type-C) is a 16-amino-acid peptide encoded within the 12S ribosomal RNA region of the mitochondrial genome — making it one of the first mitochondrial-derived peptides (MDPs) identified in human biology. It was discovered in 2015 by Changhan Lee, Pinchas Cohen, and colleagues at USC, published in Cell Metabolism. The discovery established that mitochondria, long considered purely energy-producing organelles, are also capable of producing signaling peptides that regulate metabolism and stress responses across multiple tissues.
Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015;21(3):443-454.
MOTS-C’s primary characterized mechanism involves the activation of AMPK (AMP-activated protein kinase) — the master cellular energy sensor that regulates glucose uptake, fatty acid oxidation, mitochondrial biogenesis, and autophagy. Published research has documented MOTS-C’s AMPK activation in skeletal muscle, where it promotes glucose utilization in a manner partially independent of insulin signaling — a mechanistic distinction that has driven research interest in insulin resistance and metabolic aging contexts.
A key feature of MOTS-C’s biology is its nuclear translocation: under metabolic stress conditions, MOTS-C translocates from the mitochondria to the nucleus, where it directly regulates adaptive nuclear gene expression. This cross-compartment signaling — from mitochondria to nucleus — positions MOTS-C as a genuine intracellular messenger rather than simply a local metabolic regulator.
Wan W, Zhang L, Lin Y, et al. Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging. J Transl Med. 2023;21:241. doi:10.1186/s12967-023-03885-2
Published research has documented age-related changes in circulating MOTS-C levels, though the pattern is more nuanced than simple decline. A 2020 study by D’Souza et al. in the journal Aging examined plasma and skeletal muscle MOTS-C in healthy men across three age groups (18-30, 45-55, and 70-81 years). Circulating plasma MOTS-C was reduced with age, while skeletal muscle MOTS-C expression was approximately 1.5-fold higher in older and middle-aged men compared to young men — a pattern the authors associated with age-related fast-to-slow myofiber transition and a possible compensatory response to age-related metabolic stress.
D’Souza RF, Woodhead JST, Hedges CP, et al. Increased expression of the mitochondrial derived peptide, MOTS-c, in skeletal muscle of healthy aging men is associated with myofiber composition. Aging. 2020;12:5244-5258. doi:10.18632/aging.102944
A 2021 Nature Communications study by Lee and colleagues examined MOTS-C as an exercise-induced regulator and demonstrated that MOTS-C treatment reversed age-dependent physical decline in mice, improved treadmill performance in middle-aged and old animals, and extended lifespan in cohorts starting treatment at both middle and old age. The study also established exercise as a physiological inducer of MOTS-C expression.
Kim SJ, et al. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Commun. 2021;12:470. doi:10.1038/s41467-020-20790-0
In 2024, Lee et al. published in iScience a further mechanistic study showing that MOTS-C modulates skeletal muscle function by directly binding and activating CK2 (casein kinase 2), adding another molecular target to the understanding of MOTS-C’s downstream signaling.
Lee H, Yang B, Chang B, et al. MOTS-c modulates skeletal muscle function by directly binding and activating CK2. iScience. 2024;31:111212. doi:10.1016/j.isci.2024.111212
—-
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme present in all living cells, required for redox reactions in cellular energy metabolism and serving as a substrate for two major families of enzymes with direct relevance to aging: sirtuins and PARPs. NAD+ is not simply an energy carrier — it is a signaling molecule whose availability regulates whether key aging-related enzymes can function.
Published research has consistently documented a progressive decline in NAD+ availability with age across multiple tissue types and species. A key 2012 study by Massudi et al., published in PLOS ONE, examined human skin tissue from 49 subjects aged 0-77 years and documented that DNA damage (measured via 8-OHdG) correlated strongly with age in both males and females, while NAD+ levels and SIRT1 activity declined — establishing in human tissue the relationship between age-related oxidative damage, PARP-mediated NAD+ consumption, and loss of sirtuin activity.
Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS ONE. 2012;7(7):e42357.
Sirtuins (SIRT1-7 in humans) are a family of NAD-dependent protein deacetylases with regulatory roles spanning metabolism, stress response, mitochondrial biogenesis, and DNA repair. Their dependence on NAD+ as a substrate — not a cofactor, but consumed in the reaction — means that sirtuin activity is directly sensitive to cellular NAD+ availability. When NAD+ declines with age, sirtuin activity declines with it.
David Sinclair (Harvard Medical School) and Leonard Guarente (MIT) have published extensively on the NAD+/sirtuin axis in aging. A 2016 review by Bonkowski and Sinclair in Nature Reviews Molecular Cell Biology documented the mechanistic links between NAD+ availability, sirtuin activity, mitochondrial function, and aging, and reviewed evidence from multiple model organisms. Imai and Guarente’s 2014 review in Trends in Cell Biology remains one of the most cited overviews of this research area.
Bonkowski MS, Sinclair DA. Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds. Nat Rev Mol Cell Biol. 2016;17:679-690.
Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464-471.
PARPs (poly(ADP-ribose) polymerases) are enzymes activated by DNA strand breaks. PARP1, the primary family member, catalyzes the addition of poly(ADP-ribose) chains to target proteins at damage sites, recruiting DNA repair machinery. This reaction consumes NAD+ as its substrate. Under conditions of mild to moderate DNA damage, PARP activation facilitates repair and is protective. Under conditions of excessive DNA damage — as accumulates with age — chronic PARP activation can significantly deplete cellular NAD+ pools.
The 2012 Massudi study in human tissue directly documented this dynamic: age-related increases in oxidative DNA damage were associated with PARP-mediated NAD+ depletion. A 2020 study published in Nature Metabolism (Chini et al.) further identified CD38, an ecto-enzyme induced in immune cells during aging, as a major driver of age-related NAD+ decline — adding a second, independent mechanism to the PARP-mediated pathway.
Chini CCS, Peclat TR, Warner GM, et al. CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD+ and NMN levels. Nature Metabolism. 2020;2:1284-1304.
NAD+ connects to mitochondrial function through multiple pathways. SIRT3, the primary mitochondrial sirtuin, deacetylates and activates key enzymes in the electron transport chain and TCA cycle in an NAD+-dependent manner. SIRT1 regulates PGC-1alpha — the master regulator of mitochondrial biogenesis — through NAD+-dependent deacetylation. This creates a direct mechanistic link between NAD+ availability and the mitochondrial health that MOTS-C research also addresses, though through a different molecular pathway.
—-
What the published literature establishes is a picture of cellular aging as a multi-system process in which chromosomal integrity, mitochondrial signaling, and cellular energy availability each decline through distinct mechanisms — and each represents a distinct research target.
Epitalon research addresses the chromosomal integrity axis: what happens at the level of telomere length, replicative capacity, and the hTERT/telomerase system that governs how many times cells can divide. The 25+ year research program behind this compound provides a substantial published foundation for studying telomere biology in cell culture and preclinical model systems.
MOTS-C research addresses the mitochondrial signaling axis: what the mitochondria themselves produce as regulatory signals, how those signals change with age, and what happens when MOTS-C is administered to aged animals in metabolic and exercise models. The 2015-2024 published literature on MOTS-C represents one of the most actively expanding areas in mitochondrial peptide biology.
NAD+ research addresses the cellular energy availability axis: how NAD+ levels change with age, what enzymatic systems depend on NAD+ availability, and how PARP-mediated consumption and CD38-mediated degradation contribute to the age-related decline that reduces both sirtuin activity and DNA repair capacity.
Because these three systems operate through non-overlapping primary mechanisms — telomere extension, mitochondrial AMPK signaling, and NAD+-dependent sirtuin and PARP activity — researchers interested in a comprehensive model of cellular aging examine compounds in each category rather than treating them as alternatives.
For informational purposes only. This article is a research literature review. All compounds referenced are available from Brava Longevity for research use only and are not intended for human or veterinary consumption. Nothing in this article constitutes medical advice, dosing guidance, or treatment recommendations.
